Essex Investment Management CO LLC Corcept Therapeutics Inc Transaction History

Essex Investment Management CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $4.05 Million - $6.34 Million	-403,712 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$11.29 - $17.19 $332,140 - $505,712	-29,419 Reduced 6.79%	403,712 $5.39 Million
Q3 2018 Oct 16, 2018	SELL	$12.27 - $15.65 $2,527 - $3,223	-206 Reduced 0.05%	433,131 $6.07 Million
Q2 2018 Jul 17, 2018	SELL	$15.3 - $19.69 $19,691 - $25,341	-1,287 Reduced 0.3%	433,337 $6.81 Million
Q1 2018 Apr 26, 2018	SELL	$14.59 - $25.5 $205,543 - $359,244	-14,088 Reduced 3.14%	434,624 $7.15 Million
Q4 2017 Feb 05, 2018	BUY	$15.77 - $20.72 $2.28 Million - $3 Million	144,611 Added 47.55%	448,712 $8.1 Million
Q3 2017 Oct 30, 2017	BUY	$12.3 - $19.3 $3.74 Million - $5.87 Million	304,101	304,101 $5.87 Million

368

86.8M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.29B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.